Financhill
Back

iShares MSCI New Zealand ETF Vs. ResMed Industry Stock Comparison

Sell
49

ENZL
iShares MSCI New Zealand ETF

Last Price:
45.21
Seasonality Move:
0.89%
Sell
28

RMD
ResMed

Last Price:
191.79
Seasonality Move:
6.67%
Sell
49
iShares MSCI New Zealand ETF (ENZL) is a Sell

Is iShares MSCI New Zealand ETF a Buy, Sell or Hold?

  • The current iShares MSCI New Zealand ETF [ENZL] share price is $45.35. The Score for ENZL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • ENZL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
ResMed (RMD) is a Sell

Is ResMed a Buy, Sell or Hold?

  • The current ResMed [RMD] share price is $191.58. The Score for RMD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENZL Stock Price Chart

What is iShares MSCI New Zealand ETF's stock price today?

  • The iShares MSCI New Zealand ETF share price today is $45.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENZL is experiencing slight selling pressure.

RMD Stock Price Chart

What is ResMed's stock price today?

  • The ResMed share price today is $191.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RMD is experiencing buying pressure, which is a positive indicator for future bullish movement.

ENZL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 47.4 Sell
Chaikin Money Flow: -551 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.02 - 46.52) Sell
Bollinger Bands (100): (44.68 - 46.08) Sell

RMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5 Sell
Relative Strength Index (14 RSI): 37.08 Sell
Chaikin Money Flow: 697889 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (197.23 - 216.29) Sell
Bollinger Bands (100): (182.24 - 211.22) Sell

ENZL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.49 Sell
20-day SMA: 45.94 Sell
50-day SMA: 45.33 Buy
200-day SMA: 45.37 Sell
8-day EMA: 45.53 Sell
20-day EMA: 45.65 Sell
50-day EMA: 45.54 Sell
200-day EMA: 45.88 Sell

RMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 198.23 Sell
20-day SMA: 205.63 Sell
50-day SMA: 206.74 Sell
200-day SMA: 177.34 Buy
8-day EMA: 195.6 Sell
20-day EMA: 202.78 Sell
50-day EMA: 203.63 Sell
200-day EMA: 191.94 Sell

iShares MSCI New Zealand ETF Earnings Growth & ENZL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ResMed Earnings Growth & RMD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.07 per share, an increase this year of $1.20 per share, and an increase next year of $0.90 per share.

iShares MSCI New Zealand ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ResMed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):